Home > Press > SMI announces Air Force Phase I SBIR
SMI announces receiving an Air Force Phase I SBIR award to produce thick multilayer/flux pinning YBCO tape films
Posted on May 22, 2006
Structured Materials Industries, Inc. (SMI) reports that it has received an AFOSR Phase I SBIR to develop improved current carrying superconducting films. SMI's approach is two-fold: developing CeO inter-layers combined with controlled flux pinning centers.
Copyright © SMI |
It is well known that HTC superconductor films current carrying capacity tapers off as thickness increases beyond about ½ micron. One solution is to grow multiple film layers; however to do this some interlayer must be developed. To further improve current carrying capabilities, the flux must be pinned. SMI's program addresses both issues with proprietary MOCVD technology. SMI's goal is to provide the industry with better reactors for making superconducting tapes and devices.
About Structured Materials Industries:
Structured Materials Industries, Incorporated is focused on being the leader in Metal Organic Chemical Vapor Deposition (MOCVD) and related technologies. SMI offers for sale: systems, components, materials, and process development services. SMI has an in-house applications laboratory featuring multi-reactor deposition systems and analytic capabilities, has developed a range of strategic partnerships to develop and implement MOCVD technology and looks forward to continuing to grow and expand upon mutually advantageous relationships.
For more information, please click here.
For general and technical information about this release, contact:Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||